Medicine development and delivery
The company collaborates to develop and deliver medicines for rare disease communities.
Source: LinkedIn company description · Retrieved October 13, 2026
Agios is a commercial-stage biopharmaceutical company focused on rare disease treatment.
The company draws on hematology expertise and real-world insights to advance a growing pipeline of medicines. Agios partners with rare disease communities to develop and deliver medicines.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The company collaborates to develop and deliver medicines for rare disease communities.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 3, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 16, 2026, September 18, 2026, September 19, 2026 and September 20, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.